We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
AUM
$99.8M
AUM Growth
-$9.28M
Cap. Flow
-$4.92M
Cap. Flow %
-4.93%
Top 10 Hldgs %
40.56%
Holding
70
New
5
Increased
16
Reduced
42
Closed
5

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$1.92M
2
MXL icon
MaxLinear
MXL
+$1.25M
3
VCEL icon
Vericel Corp
VCEL
+$961K
4
TLGT
Teligent, Inc
TLGT
+$892K
5
CELG
Celgene Corp
CELG
+$386K

Sector Composition

Rank Sector Weight
1 Healthcare 43.66%
2 Technology 35.86%
3 Industrials 5.22%
4 Financials 3.86%
5 Miscellaneous 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENT
1
DELISTED
Intersect ENT, Inc
XENT
$6.54M 6.55%
201,943
-22,429
-10% -$673K
OCLR
2
DELISTED
Oclaro Inc.
OCLR
$6.05M 6.06%
897,000
+14,169
+2% +$105K
CALD
3
DELISTED
Callidus Software, Inc.
CALD
$3.86M 3.86%
134,655
-4,377
-3% -$119K
SRGA
4
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.71M 3.72%
30,193
-1,734
-5% -$238K
FNSR
5
DELISTED
Finisar Corp
FNSR
$3.61M 3.62%
177,596
-3,945
-2% -$82K
NEO icon
6
NeoGenomics
NEO
$2.39B
$3.6M 3.61%
406,444
-47,904
-11% -$442K
TLGT
7
DELISTED
Teligent, Inc
TLGT
$3.47M 3.48%
95,653
+18,639
+24% +$892K
OMCL icon
8
Omnicell
OMCL
$1.52B
$3.34M 3.34%
68,841
-2,886
-4% -$146K
IDTI
9
DELISTED
Integrated Device Technology I
IDTI
$3.29M 3.29%
110,518
-4,743
-4% -$143K
MXL icon
10
MaxLinear
MXL
$5.75B
$3.02M 3.03%
114,352
+50,160
+78% +$1.25M
LGND icon
11
Ligand Pharmaceuticals
LGND
$5.67B
$3.02M 3.02%
35,308
-32
-0.1% -$2.77K
PODD icon
12
Insulet
PODD
$9.95B
$2.94M 2.94%
42,614
-2,219
-5% -$146K
CVLT icon
13
Commault Systems
CVLT
$5.82B
$2.76M 2.76%
52,557
-1,599
-3% -$88.5K
SWKS icon
14
Skyworks Solutions
SWKS
$10.1B
$2.41M 2.41%
25,353
-1,371
-5% -$143K
NXTM
15
DELISTED
NxStage Medical Inc.
NXTM
$2.39M 2.39%
98,668
-7,918
-7% -$209K
ATRC icon
16
AtriCure
ATRC
$2.51B
$2.32M 2.33%
127,435
+12,836
+11% +$254K
EGHT icon
17
8x8 Inc
EGHT
$290M
$2.05M 2.05%
145,350
-4,320
-3% -$59.7K
IMPV
18
DELISTED
Imperva, Inc.
IMPV
$1.89M 1.89%
47,637
-2,246
-5% -$93.6K
QRVO icon
19
Qorvo
QRVO
$8.49B
$1.78M 1.78%
26,674
-5,256
-16% -$383K
SUPN icon
20
Supernus Pharmaceuticals
SUPN
$2.57B
$1.76M 1.76%
44,121
-1,710
-4% -$67.6K
CYBR
21
DELISTED
CyberArk
CYBR
$1.73M 1.73%
41,694
-1,754
-4% -$76.8K
GTLS
22
DELISTED
Chart Industries
GTLS
$1.68M 1.68%
35,877
-2,004
-5% -$89.4K
TWLO icon
23
Twilio
TWLO
$37.1B
$1.62M 1.62%
+68,477
New +$1.92M
VCEL icon
24
Vericel Corp
VCEL
$2.11B
$1.6M 1.6%
293,070
+208,368
+246% +$961K
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.53M 1.54%
105,126
-6,389
-6% -$89.7K

Similar funds

Kopp Investment Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Kopp Investment Advisors held 70 positions worth $99.8M, down 8.5% from $109M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Kopp Investment Advisors withdrew a net $4.92M in Q4 2017, closing 5 positions and reducing 42 holdings. Its most notable exit was Akorn Inc, an estimated $3.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

Against the trend, Kopp Investment Advisors opened a new position in Twilio worth $1.62M.

  • Kopp Investment Advisors's largest Q4 2017 buy was Twilio: 68,477 shares worth $1.62M.
  • Kopp Investment Advisors added most to MaxLinear in Q4 2017, an estimated $1.25M increase.
  • Kopp Investment Advisors's biggest Q4 2017 reduction was K2M Group Holdings, Inc, cutting an estimated $708K.
  • Kopp Investment Advisors fully exited Akorn Inc in Q4 2017, selling an estimated $3.61M.
  • Kopp Investment Advisors's ten largest holdings make up 41% of its $99.8M portfolio in Q4 2017.
  • Kopp Investment Advisors opened 5 new positions and closed 5 in Q4 2017.
  • Kopp Investment Advisors's portfolio value fell 8.5% quarter-over-quarter to $99.8M.

Based on Kopp Investment Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.